Delivery Order SPE2DB25D3109-SPE2DB25FPJSA

Award Date 1/6/25
Potential Completion Date 1/7/25
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens, a medication used to treat type 2 diabetes. The contract has a ceiling value of $21,266.51 and a period of performance through August 14, 2024. It is a firm-fixed price contract, and there is no set-aside designation. AmerisourceBergen holds a large Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL, a medication used to treat type 2 diabetes. The contract has a ceiling value of $4,713.24 and is a firm fixed-price delivery order with a completion date of May 6, 2024. AmerisourceBergen holds a larger Indefinite Delivery...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens, a medication used for the treatment of diabetes. The delivery order has a ceiling value of $11,945.58 and a completion date of September 6, 2024. This order is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL sizes, which are used to treat type 2 diabetes. The contract has a firm fixed price of $8,559.48 and a period of performance ending on September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Ozempic 0.25-0.5 mg/dose pens, a medication used for diabetes management. The total ceiling value of the contract is $13,119.44, with a completion date of December 30, 2024. The contract is a firm fixed-price arrangement and was not set aside for any specific business type....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat diabetes. The contract has a ceiling value of $6,295.60 and a completion date of August 9, 2024. This award is a firm fixed-price delivery order and is not designated as a set-aside contract. AmerisourceBergen Drug Corp is the prime contractor, and there...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic (0.25-0.5 mg/dose pen, 3 mL), a medication used for the treatment of diabetes. The contract has a ceiling value of $3,678.12 and a completion date of April 13, 2023. It is a firm-fixed-price contract, and there was no set-aside designation used. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used for the treatment of diabetes. The contract has a ceiling value of $3,284.73 and a period of performance through December 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens. The delivery order, valued at $1,741.62, is a firm fixed-price contract with a completion date of August 26, 2024. It is not associated with a set-aside program. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used for the treatment of type 2 diabetes. The contract has a firm fixed price of $4,933.08 and a completion date of November 1, 2024. The contract was not set aside for any particular business type. AmerisourceBergen holds a significant...
  • SPE2DB25D3109
    Indefinite Delivery Contract
  • SPE2DB25D3109-SPE2DB25FPJSA
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens, a medication used for the treatment of type 2 diabetes. The contract has a ceiling value of $3,759.96 and a completion date of January 7, 2025. It is a firm fixed-price contract and was not set aside for any specific business size or socioeconomic category. AmerisourceBergen Drug Corp is the prime contractor and there is no information provided about any subcontractors. This contract appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which covers a comprehensive range of pharmaceutical products and medical supplies for military healthcare programs.

Generated 4/7/25, 9:42 AM